Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 6, 1997 - Issue 4
Submit an article Journal homepage
18
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report

The 98th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics

William E Heydorn Director of Pharmaceutical Operations, Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, NJ 07652, USA; Tel: +1 201-261-1331, extension 114; Fax: +1 201-261-0623;[email protected])
Pages 453-457 | Published online: 23 Feb 2005

Bibliography

  • ROTHMAN KJ, MICHELS KB: The continuing unethicaluse of placebo-controlled-controls. New Engl. J. Med. (1994) 331:394–398.
  • SPILKER B: Guide to Clinical Trials. Raven Press, New York(199 1): 255–257.
  • ROGERS SL, FRIEDHOFF LT: The pharmacokinetic (PK)and pharmacodynamic (PD) profile of donepezil HCL (E2020) following single and multiple oral doses. Clin. Pharmacol. Ther. (1997) 61:181.
  • TISERO PJ, ROGERS SL, FRIEDHOFF LT: The pharmacok-inetic profile of donepezil HCL (E2020) in patients with impaired liver function. Clin. Pharmacol. Ther. (1997) 61:184.
  • FRIEDHOFF LT, ROGERS SL: Correlation between theclinical efficacy of done pezil HCL (E2020) and red blood cell (RBC) acetylcholinesterase (ACHE) inhibition in patients with Alzheimer's disease (AD). Clin. Pharmacol Ther. (1997) 61:177.
  • SUTT LE AB, VARGO DL, WILKINSON LA, BIRMINGHAM BK,LASSETER K: Effect of zafirlukast on the pharmacolcinet-ics of R- and S-war farin in healthy men Clin. Pharmacol Ther. (1997) 61:186.
  • MAURATH C, UN T, HOSMANE B, JORDAN D, PADLEY RJ:Dose-response of adverse events (AE) in titration stud-ies of ter az osin inpatients with benign pr ostatic hyp er-plasia (BPH). Clin. Pharmacol. Ther. (1997) 61:137.
  • VASHI V, PENENBERG D, CHUNG M, WALMSLEY P: Effectof hepatic impairment on the pharmacokinetics of doxazosin. Clin. Pharmacol Ther. (1997) 61:159.
  • GOLDSTEIN DJ, WANG 0: Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Clin. Pharmacol. Ther. (1997) 61:142.
  • SHAH AK, HARRIS SC: Pharmacokinetics (PK) of eletrip-tan (E) following escalating single oral doses in healthy male subjects. Clin. Pharmacol. Ther. (1997) 61:142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.